Literature DB >> 2929394

Surgical treatment of multiple aneurysms. Review of experience with 372 cases.

K Mizoi1, J Suzuki, T Yoshimoto.   

Abstract

We review the surgical results in 372 cases of multiple intracranial aneurysms over a 25-year period in which one of us (JS) performed 2,000 direct operations for aneurysms. All patients were classified into four groups according to the location of the aneurysm: Group 1: multiple aneurysms including anterior communicating artery aneurysm (157 cases); Group 2: multiple aneurysms of unilateral anterior circulation (72 cases); Group 3: multiple aneurysms of bilateral anterior circulation (110 cases); Group 4: multiple aneurysms including vertebro-basilar artery aneurysms (33 cases). In multiple aneurysm cases, our policy has been to treat all aneurysms, ruptured and unruptured, in a one-stage operation whenever possible. About 90% of patients in both Group 1 and 2 were treated by one-stage operations, while 60% of patients in Group 3 and 42% of patients in Group 4 were operated on in the same manner. Excellent and good results in from 73% to 81% of cases were obtained in patients in Group 1, Group 2 and Group 3. Morbidity was 14-19% and mortality was 6-8%. These results were comparable to the results with a single aneurysm of the anterior circulation. On the other hand, the surgical results in Group 4 were poor with a mortality of 27%. Poor results were attributable to the postoperative rebleeding from the untreated vertebro-basilar aneurysms, which were thought to be unruptured aneurysms preoperatively. Furthermore, it was clarified that the results of early one-stage operations (within one week from onset) in patients with multiple aneurysms were satisfactory. In this group, there was good recovery in 84% of patients, 7% were disabled and 9% died.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2929394     DOI: 10.1007/BF01403489

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  21 in total

1.  ANGIOGRAPHIC IDENTIFICATION OF THE RUPTURED LESION IN PATIENTS WITH MULTIPLE CEREBRAL ANEURYSMS.

Authors:  E H WOOD
Journal:  J Neurosurg       Date:  1964-03       Impact factor: 5.115

2.  MULTIPLE INTRACRANIAL ANEURYSMS.

Authors:  W MCKISSOCK; A RICHARDSON; L WALSH; E OWEN
Journal:  Lancet       Date:  1964-03-21       Impact factor: 79.321

3.  Value of neurological and angiographic signs as indicators of the ruptured aneurysm in patients with multiple intracranial aneurysms.

Authors:  I Marttila; O Heiskanen
Journal:  Acta Neurochir (Wien)       Date:  1970       Impact factor: 2.216

4.  Value of computed tomography in the diagnosis and management of subarachnoid hemorrhage.

Authors:  L M Modesti; E F Binet
Journal:  Neurosurgery       Date:  1978 Sep-Oct       Impact factor: 4.654

5.  Bifrontal interhemispheric approach for carotid-ophthalmic aneurysms.

Authors:  K Mizoi; J Suzuki; T Kinjo; T Yoshimoto
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

6.  Risks of surgery for unruptured intracranial aneurysms.

Authors:  O Heiskanen
Journal:  J Neurosurg       Date:  1986-10       Impact factor: 5.115

7.  Computed tomography in aneurysmal subarachnoid hemorrhage.

Authors:  L A Weisberg
Journal:  Neurology       Date:  1979-06       Impact factor: 9.910

8.  Surgical treatment of middle cerebral artery aneurysms.

Authors:  J Suzuki; T Yoshimoto; T Kayama
Journal:  J Neurosurg       Date:  1984-07       Impact factor: 5.115

9.  Risk of bleeding from unruptured aneurysm in cases with multiple intracranial aneurysms.

Authors:  O Heiskanen
Journal:  J Neurosurg       Date:  1981-10       Impact factor: 5.115

10.  Multiple intracranial aneurysms: determining the site of rupture.

Authors:  D G Nehls; R A Flom; L P Carter; R F Spetzler
Journal:  J Neurosurg       Date:  1985-09       Impact factor: 5.115

View more
  21 in total

1.  Multiple intracranial aneurysms. Angiographic study and endovascular treatment.

Authors:  F Mont'alverne; A Tournade; C Riquelme; M Musacchio
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

2.  Surgical treatment of multiple intracranial aneurysms.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  Risk-benefit analysis of the treatment of unruptured intracranial aneurysms.

Authors:  R R Vindlacheruvu; A D Mendelow; P Mitchell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

4.  A long-term follow-up study in direct cerebral aneurysm surgery.

Authors:  H Kamitani; H Masuzawa; I Kanazawa; T Kubo; Y Tokuyama
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

5.  Multiple intracranial aneurysms: surgical treatment and outcome.

Authors:  L Cervoni; R Delfini; A Santoro; G Cantore
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Multiple intracranial aneurysms in elderly patients.

Authors:  T Inagawa
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  Long term prognosis of symptomatic and asymptomatic cerebral aneurysms.

Authors:  M Samardzic; D Grujicic; L Djordjic; M Joksimovic
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

8.  Surgical management of unruptured intracranial aneurysms. Personal experience with 37 cases and discussion of the indications.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; L Bognar; A Oubouklik
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

9.  Multiple intracranial aneurysms: endovascular treatment and complications.

Authors:  Xun Shen; Tao Xu; Xuan Ding; Wenlei Wang; Zhi Liu; Huaihai Qin
Journal:  Interv Neuroradiol       Date:  2014-08-28       Impact factor: 1.610

10.  Bilateral middle cerebral artery aneurysms: a comparative study of unilateral and bilateral approaches.

Authors:  Servet Inci; Atilla Akbay; Tuncalp Ozgen
Journal:  Neurosurg Rev       Date:  2012-05-12       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.